Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01191021 · ClinicalTrials.gov registry record · Phase 1
Monitoring Exhaled Propofol to Individualize General Anesthesia
A Phase 1 study of General Anesthesia, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01191021 is a Phase 1 study of General Anesthesia that has completed, run by University of California, San Francisco. The registered enrollment target is 20 participants, below the 1,633-participant average among 4 other General Anesthesia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01191021, a Phase 1 study of General Anesthesia, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial investigates the relationship between concentrations of the anesthetic drug propofol in exhaled breath, blood and drug effect in volunteers undergoing general anesthesia. The main goal of this study is to develop a pharmacokinetic - and dynamic model for propofol in exhaled breath.
Conditions Studied
Interventions
- DRUG Propofol Anesthesia
Study Locations (1)
California
- Department of Anesthesia and Perioperative Care, UCSF - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01191021
The ClinicalTrials.gov registry entry for NCT01191021 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,633-participant average among 4 other General Anesthesia trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with General Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Propofol Anesthesia is the first listed.
NCT01191021 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01191021 about?
NCT01191021 is a clinical study titled "Monitoring Exhaled Propofol to Individualize General Anesthesia". This trial investigates the relationship between concentrations of the anesthetic drug propofol in exhaled breath, blood and drug effect in volunteers undergoing general anesthesia. The main goal of this study is to develop a pharmacokinetic - and dynamic model for propofol in exhaled breath.
What is the current status of trial NCT01191021?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2010-10.
What conditions does trial NCT01191021 study?
This clinical trial studies the following conditions: General Anesthesia.
What interventions are being tested in trial NCT01191021?
The interventions under investigation include: Propofol Anesthesia (DRUG).
Who is sponsoring clinical trial NCT01191021?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01191021 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for General Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users
COMPLETED · Phase 1
-
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
RECRUITING · Phase 4
-
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
RECRUITING
-
Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness.
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.